HI
SILO icon

Harbour Investments’s Silo Pharma SILO Stock Holding History

Harbour Investments’s Portfolio SILO Stock Details SILO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87 Buy
+14
New +$90 ﹤0.01% 4626

Other funds holding SILO

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Harbour Investments's SILO Position: Q2 2026 in Review

Harbour Investments opened a new position in Silo Pharma (SILO) in Q2 2026: 14 shares worth $87. The stake represents ﹤0.01% of the portfolio and ranks #4626 among its holdings.

9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

  • Harbour Investments held 14 shares of Silo Pharma worth $87 as of Q2 2026.
  • Silo Pharma was a new Harbour Investments position in Q2 2026.
  • Silo Pharma made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4626 holding.
  • 9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.